{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"alpha-n-acetylgalactosaminidase-deficiency-type-1","columns":[{"gene":"","key":"population-cea9a7159f064e0c1941","label":"Schindler disease, type I","mondoId":"MONDO:0012221","onsetQualifier":null,"originColumnKey":"MONDO:0012221/OMIM:609241","originalViews":[{"key":"MONDO:0012221/OMIM:609241","label":"Schindler disease, type I","scopeLabel":"OMIM:609241","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["11d8e3444a0ea4fd1692989cb520ee23958dc61771a44d873c10c5ed00082882","27e9bcdc4d747802a722f25e1d2bc23c287f0feda616a561060a3f5d5ef740b2","2d042028963773bc4ed5eaf8ca488e1f226f4244795449e59723c645d1820116","4d7eb7581e528e2e2ff38f91e4cbb13dc8f8af960d15894a96a100476df480a6","5186c8894e85826b6cda6a1849831fa721813be091c788daa1bfbeb77a2a9620","60f48996577cdb8feedd46003f27dab238803ef98a549a4490b447b36164eb16","6561805841793dde82150e56f5306db6872f979caabeee0e591161597d966084","66d6ded129922f4461e418317bbacbc249dad08c84484d022fac8da59836dc63","7188630725290b8b30c9755af8e74fdc9d9ee1010b7a579fe6d712f3663ce4d2","96352fd58d1df20e3ad9028a047889189be52507a520396150716d64fbcbab7e","a996ed939d682778d70202b029f1ec6444652f992fce378565f40dca43cb4224","b411ce4aa92f691278d4a205d167c51a751c9d92c62849d70ff87a140c3cd40f","db0b6f9ea2b6c2f5b0e6a822b6371f8b1d209365de8d3ff9ae28dd4079f42a0b","dddd80956011d9347ed2d208ee3ee4ad60dade450c0b20d81a3f0d4fb3bee08d","ec182c7b11f007e4d4e1d4c98db71b9f42652c8496ec1cb7f346ea3d5ee5a51c","f4d8e624bf1265f985da104805131a250ec2cb8d370e96fe42eed75358c9f0bd","f8709a572d6f7b7682d706119ea9b1316819cf196f5f4d51dfcc22697c02e0df"],"recordQualifiers":{},"scopeLabel":"OMIM:609241","sourceIds":["OMIM:609241"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-fc0115c3caf25b6d649c","label":"Alpha-N-acetylgalactosaminidase deficiency type 1","mondoId":"MONDO:0012221","onsetQualifier":null,"originColumnKey":"MONDO:0012221/ORPHA:79279","originalViews":[{"key":"MONDO:0012221/ORPHA:79279","label":"Alpha-N-acetylgalactosaminidase deficiency type 1","scopeLabel":"ORPHA:79279","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0001050b79b7807e9cfe104689c5c1500eca5f984a304542f5eabc84d8e2fffa","0cd33bd30eadfeb920e59d136f7485f2c30810c1511387b7f25ec9450436f7be","1333124c9b9c53976dd2d5f4ddf3079dc3e2474d03c6da6d7333c58e6ba12bf8","192a289fd4477e5be6af9d0064c9105a6f7053d54979ecd357bf2c4af4dde3a8","21b6c0588561788c7f7c1341e5654b27831d6febd81a9a256e1fd8da90772fc9","24b84be1bd0698a7e39877295125cfb86651647309be4fe56c63caacd9d05a02","3219d13055e03683e3e7e9be4b28d652a00b83a18aef2c5c170b06e426d584af","3a4de9a0d81843ea24950ea2b620e79637c20bc39c3572a8e2384f7f92b38659","425d5b65dace2a456cd850df54bb8dfb49cc4352e0448ef770451972db0e078c","4b3f6bc46586a9c40604e64bb481643d77cde13ed03aa3b2d60bd6722dfa4aa1","51ee1611f4621f7a6066801135a40552b482842b6abe885eed4ce426416c45c2","55125a159f63018ae641b183e66569037b9b5c7284ec5ec72ace357366453529","5b2c928ae3dbc725b4c4d4b730265a98c35fd04bca926c3d080d6d7180dade03","61bd551d3a67f0bbb66957a7ff4923ed642664d1ad48d69b71566cbf2503618d","6306e92ae5065204361534b48833ed0d3b5f1d6be7ce6432b5552b67edb467cb","7788320501a10aebbf40ed1a6f7bff9b63807db9a2f3fda3bc61941d226f8f81","8ba15a7dd55575bff515af36820e51011fcf50efa9f1339173a0c4c234062289","8ef5e6420a923a638aae2c89d15294e65a1e156df6ab134fc20ecd90d744a666","90585e83b183eaff85ab97fb0a2bbb6a7e126a96fef7fa199c59ca1ef4c20eb7","9936f72e71da7e43fe2ce6a383682a3e217191e648f871a601ac1b0b98147528","9b99e24979bed7a884f6abac879482456b02d403a1b2738a2ab496618679555e","9e688967641dc8f61df86020a5a0c69f8a3677e375c43f30452f2e5dd175b31b","a19bf86382067ad15db86aeaf86aa75020805d27e59cd8e4c490874c48e7dbf4","a2b632edece62394dfd4aa3544514d3121f71a35c80515a6297495598e16e63d","c8bf053549fd747a04db413afa8416df060c2fe8008a95d4fe5de3cd85ee23f5","cf281a46cd1be5c9cf8bb969f553704ca2364395fa5a2474628ecf52b413afe3","d202c690d9a11d765715e0cff128f9e22c43b23241194143c1486c9e6476a95a","d7357be5048807f72385e3239b39190441540ad278c1f3cf7d105b425822313f","da98f239439f2658f5cecf65d15737d8a5787f1a6555928dd9242ba64c645e9c","dfce6c0bab36dba6f9ba1ad32ab628413524301d25211e34dd7c8c44bb3aab28"],"recordQualifiers":{},"scopeLabel":"ORPHA:79279","sourceIds":["ORPHA:79279"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-cea9a7159f064e0c1941","population-fc0115c3caf25b6d649c"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0002363","HP:0007256","HP:0002071","HP:0007360","HP:0000717","HP:0100704","HP:0002376"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":47,"sourceGroups":{"omim":17,"orphanet":30}},"features":[{"hpoId":"HP:0002363","label":"Abnormal brainstem morphology","primary":true},{"hpoId":"HP:0007256","label":"Abnormal pyramidal sign","primary":true},{"hpoId":"HP:0002071","label":"Abnormality of extrapyramidal motor function","primary":true},{"hpoId":"HP:0007360","label":"Aplasia/Hypoplasia of the cerebellum","primary":true},{"hpoId":"HP:0000717","label":"Autism","primary":true},{"hpoId":"HP:0100704","label":"Cerebral visual impairment","primary":true},{"hpoId":"HP:0002376","label":"Developmental regression","primary":true},{"hpoId":"HP:0003700","label":"Generalized amyotrophy","primary":false},{"hpoId":"HP:0001290","label":"Generalized hypotonia","primary":false},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0000365","label":"Hearing impairment","primary":false},{"hpoId":"HP:0004374","label":"Hemiplegia/hemiparesis","primary":false},{"hpoId":"HP:0002240","label":"Hepatomegaly","primary":false},{"hpoId":"HP:0000962","label":"Hyperkeratosis","primary":false},{"hpoId":"HP:0001347","label":"Hyperreflexia","primary":false},{"hpoId":"HP:0001639","label":"Hypertrophic cardiomyopathy","primary":false},{"hpoId":"HP:0001252","label":"Hypotonia","primary":false},{"hpoId":"HP:0003461","label":"Increased urinary O-linked sialopeptides","primary":false},{"hpoId":"HP:0001004","label":"Lymphedema","primary":false},{"hpoId":"HP:0001324","label":"Muscle weakness","primary":false},{"hpoId":"HP:0001336","label":"Myoclonus","primary":false},{"hpoId":"HP:0000639","label":"Nystagmus","primary":false},{"hpoId":"HP:0000648","label":"Optic atrophy","primary":false},{"hpoId":"HP:0000938","label":"Osteopenia","primary":false},{"hpoId":"HP:0003401","label":"Paresthesia","primary":false},{"hpoId":"HP:0009830","label":"Peripheral neuropathy","primary":false},{"hpoId":"HP:4000202","label":"Reduced tissue alpha-N-acetylgalactosaminidase activity","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0000763","label":"Sensory neuropathy","primary":false},{"hpoId":"HP:0010864","label":"Severe intellectual disability","primary":false},{"hpoId":"HP:0001257","label":"Spasticity","primary":false},{"hpoId":"HP:0000486","label":"Strabismus","primary":false},{"hpoId":"HP:0001009","label":"Telangiectasia","primary":false},{"hpoId":"HP:0100585","label":"Telangiectasia of the skin","primary":false},{"hpoId":"HP:0002321","label":"Vertigo","primary":false}],"ledeHtml":"Alpha-N-acetylgalactosaminidase deficiency type 1 is an inherited condition that primarily causes neurological problems. There are three types of Alpha-N-acetylgalactosaminidase deficiencies. Alpha-N-acetylgalactosaminidase deficiency type 1, also called the infantile type, is the most severe form. Affected individuals may have developmental delay, developmental regression (they lose developmental skills), blindness, and seizures, and they eventually lose awareness of their surroundings and become unresponsive. People with this form of the condition usually don&#x27;t survive past early childhood. Alpha-N-acetylgalactosaminidase deficiency type 1 is caused by genetic changes in the NAGA gene. The condition follows an autosomal recessive pattern of inheritance.","mondoId":"MONDO:0012221","node":{"canonicalSlug":"alpha-n-acetylgalactosaminidase-deficiency-type-1","comparisons":[{"documentSha256":"2facb2312f03bf0e989baa741e010b8bf29f85bb76065a9a8e7cdd299182b27a","key":"legacy-alpha-n-acetylgalactosaminidase-deficiency","kind":"legacy","label":"alpha-N-acetylgalactosaminidase deficiency","memberIds":["MONDO:0012221","MONDO:0012222","MONDO:0017779","MONDO:0019264"],"mondoId":"MONDO:0017779","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/alpha-n-acetylgalactosaminidase-deficiency.2facb2312f03bf0e989baa741e010b8bf29f85bb76065a9a8e7cdd299182b27a.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Alpha-N-acetylgalactosaminidase deficiency type 1","originalSourceId":"ORPHA:79279","paragraphs":["Alpha-N-acetylgalactosaminidase deficiency type 1 is an inherited condition that primarily causes neurological problems. There are three types of Alpha-N-acetylgalactosaminidase deficiencies. Alpha-N-acetylgalactosaminidase deficiency type 1, also called the infantile type, is the most severe form. Affected individuals may have developmental delay, developmental regression (they lose developmental skills), blindness, and seizures, and they eventually lose awareness of their surroundings and become unresponsive. People with this form of the condition usually don't survive past early childhood. Alpha-N-acetylgalactosaminidase deficiency type 1 is caused by genetic changes in the NAGA gene. The condition follows an autosomal recessive pattern of inheritance."],"rawAttribution":"MONDO:0012221","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:38:10Z","upstream":"GARD:0000116","url":"https://rarediseases.info.nih.gov/diseases/116"},"ownColumnKeys":["population-cea9a7159f064e0c1941","population-fc0115c3caf25b6d649c"],"publication":"published","relationships":[{"kind":"parent","label":"alpha-N-acetylgalactosaminidase deficiency","mondoId":"MONDO:0017779","slug":"alpha-n-acetylgalactosaminidase-deficiency"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"0001050b79b7807e9cfe104689c5c1500eca5f984a304542f5eabc84d8e2fffa","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001639","is_excluded":false,"label":"Hypertrophic cardiomyopathy","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0cd33bd30eadfeb920e59d136f7485f2c30810c1511387b7f25ec9450436f7be","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001324","is_excluded":false,"label":"Muscle weakness","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"11d8e3444a0ea4fd1692989cb520ee23958dc61771a44d873c10c5ed00082882","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:609241","disease_name":"Schindler disease, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001257","is_excluded":false,"label":"Spasticity","onset_id":null,"reference":"OMIM:609241","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"1333124c9b9c53976dd2d5f4ddf3079dc3e2474d03c6da6d7333c58e6ba12bf8","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100585","is_excluded":false,"label":"Telangiectasia of the skin","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"192a289fd4477e5be6af9d0064c9105a6f7053d54979ecd357bf2c4af4dde3a8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002071","is_excluded":false,"label":"Abnormality of extrapyramidal motor function","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"21b6c0588561788c7f7c1341e5654b27831d6febd81a9a256e1fd8da90772fc9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0007360","is_excluded":false,"label":"Aplasia/Hypoplasia of the cerebellum","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"24b84be1bd0698a7e39877295125cfb86651647309be4fe56c63caacd9d05a02","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002321","is_excluded":false,"label":"Vertigo","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"27e9bcdc4d747802a722f25e1d2bc23c287f0feda616a561060a3f5d5ef740b2","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:609241","disease_name":"Schindler disease, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0100704","is_excluded":false,"label":"Cerebral visual impairment","onset_id":null,"reference":"OMIM:609241","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"2d042028963773bc4ed5eaf8ca488e1f226f4244795449e59723c645d1820116","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:609241","disease_name":"Schindler disease, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0010864","is_excluded":false,"label":"Severe intellectual disability","onset_id":null,"reference":"OMIM:609241","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"3219d13055e03683e3e7e9be4b28d652a00b83a18aef2c5c170b06e426d584af","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3a4de9a0d81843ea24950ea2b620e79637c20bc39c3572a8e2384f7f92b38659","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000717","is_excluded":false,"label":"Autism","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"425d5b65dace2a456cd850df54bb8dfb49cc4352e0448ef770451972db0e078c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002376","is_excluded":false,"label":"Developmental regression","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4b3f6bc46586a9c40604e64bb481643d77cde13ed03aa3b2d60bd6722dfa4aa1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"4d7eb7581e528e2e2ff38f91e4cbb13dc8f8af960d15894a96a100476df480a6","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:609241","disease_name":"Schindler disease, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:4000202","is_excluded":false,"label":"Reduced tissue alpha-N-acetylgalactosaminidase activity","onset_id":null,"reference":"OMIM:609241","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"5186c8894e85826b6cda6a1849831fa721813be091c788daa1bfbeb77a2a9620","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:609241","disease_name":"Schindler disease, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001290","is_excluded":false,"label":"Generalized hypotonia","onset_id":null,"reference":"OMIM:609241","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"51ee1611f4621f7a6066801135a40552b482842b6abe885eed4ce426416c45c2","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001004","is_excluded":false,"label":"Lymphedema","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"55125a159f63018ae641b183e66569037b9b5c7284ec5ec72ace357366453529","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000365","is_excluded":false,"label":"Hearing impairment","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5b2c928ae3dbc725b4c4d4b730265a98c35fd04bca926c3d080d6d7180dade03","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0004374","is_excluded":false,"label":"Hemiplegia/hemiparesis","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"60f48996577cdb8feedd46003f27dab238803ef98a549a4490b447b36164eb16","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:609241","disease_name":"Schindler disease, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001336","is_excluded":false,"label":"Myoclonus","onset_id":null,"reference":"OMIM:609241","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"61bd551d3a67f0bbb66957a7ff4923ed642664d1ad48d69b71566cbf2503618d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003401","is_excluded":false,"label":"Paresthesia","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6306e92ae5065204361534b48833ed0d3b5f1d6be7ce6432b5552b67edb467cb","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001336","is_excluded":false,"label":"Myoclonus","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"6561805841793dde82150e56f5306db6872f979caabeee0e591161597d966084","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:609241","disease_name":"Schindler disease, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000486","is_excluded":false,"label":"Strabismus","onset_id":null,"reference":"OMIM:609241","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"66d6ded129922f4461e418317bbacbc249dad08c84484d022fac8da59836dc63","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:609241","disease_name":"Schindler disease, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002376","is_excluded":false,"label":"Developmental regression","onset_id":null,"reference":"OMIM:609241","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"7188630725290b8b30c9755af8e74fdc9d9ee1010b7a579fe6d712f3663ce4d2","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:609241","disease_name":"Schindler disease, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"OMIM:609241","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"7788320501a10aebbf40ed1a6f7bff9b63807db9a2f3fda3bc61941d226f8f81","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000763","is_excluded":false,"label":"Sensory neuropathy","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8ba15a7dd55575bff515af36820e51011fcf50efa9f1339173a0c4c234062289","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8ef5e6420a923a638aae2c89d15294e65a1e156df6ab134fc20ecd90d744a666","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003700","is_excluded":false,"label":"Generalized amyotrophy","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"90585e83b183eaff85ab97fb0a2bbb6a7e126a96fef7fa199c59ca1ef4c20eb7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0009830","is_excluded":false,"label":"Peripheral neuropathy","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"96352fd58d1df20e3ad9028a047889189be52507a520396150716d64fbcbab7e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:609241","disease_name":"Schindler disease, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"OMIM:609241","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"9936f72e71da7e43fe2ce6a383682a3e217191e648f871a601ac1b0b98147528","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000486","is_excluded":false,"label":"Strabismus","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9b99e24979bed7a884f6abac879482456b02d403a1b2738a2ab496618679555e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001257","is_excluded":false,"label":"Spasticity","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9e688967641dc8f61df86020a5a0c69f8a3677e375c43f30452f2e5dd175b31b","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0100704","is_excluded":false,"label":"Cerebral visual impairment","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a19bf86382067ad15db86aeaf86aa75020805d27e59cd8e4c490874c48e7dbf4","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002363","is_excluded":false,"label":"Abnormal brainstem morphology","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a2b632edece62394dfd4aa3544514d3121f71a35c80515a6297495598e16e63d","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000962","is_excluded":false,"label":"Hyperkeratosis","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"a996ed939d682778d70202b029f1ec6444652f992fce378565f40dca43cb4224","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:609241","disease_name":"Schindler disease, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001347","is_excluded":false,"label":"Hyperreflexia","onset_id":null,"reference":"OMIM:609241","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"b411ce4aa92f691278d4a205d167c51a751c9d92c62849d70ff87a140c3cd40f","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:609241","disease_name":"Schindler disease, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000938","is_excluded":false,"label":"Osteopenia","onset_id":null,"reference":"OMIM:609241","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"c8bf053549fd747a04db413afa8416df060c2fe8008a95d4fe5de3cd85ee23f5","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001009","is_excluded":false,"label":"Telangiectasia","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cf281a46cd1be5c9cf8bb969f553704ca2364395fa5a2474628ecf52b413afe3","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0007256","is_excluded":false,"label":"Abnormal pyramidal sign","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d202c690d9a11d765715e0cff128f9e22c43b23241194143c1486c9e6476a95a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d7357be5048807f72385e3239b39190441540ad278c1f3cf7d105b425822313f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0010864","is_excluded":false,"label":"Severe intellectual disability","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"da98f239439f2658f5cecf65d15737d8a5787f1a6555928dd9242ba64c645e9c","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"db0b6f9ea2b6c2f5b0e6a822b6371f8b1d209365de8d3ff9ae28dd4079f42a0b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:609241","disease_name":"Schindler disease, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003461","is_excluded":false,"label":"Increased urinary O-linked sialopeptides","onset_id":null,"reference":"OMIM:609241","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"dddd80956011d9347ed2d208ee3ee4ad60dade450c0b20d81a3f0d4fb3bee08d","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:609241","disease_name":"Schindler disease, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"OMIM:609241","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"dfce6c0bab36dba6f9ba1ad32ab628413524301d25211e34dd7c8c44bb3aab28","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79279","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000639","is_excluded":false,"label":"Nystagmus","onset_id":null,"reference":"ORPHA:79279","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"ec182c7b11f007e4d4e1d4c98db71b9f42652c8496ec1cb7f346ea3d5ee5a51c","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:609241","disease_name":"Schindler disease, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000639","is_excluded":false,"label":"Nystagmus","onset_id":null,"reference":"OMIM:609241","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"f4d8e624bf1265f985da104805131a250ec2cb8d370e96fe42eed75358c9f0bd","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:609241","disease_name":"Schindler disease, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"OMIM:609241","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"f8709a572d6f7b7682d706119ea9b1316819cf196f5f4d51dfcc22697c02e0df","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:609241","disease_name":"Schindler disease, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003700","is_excluded":false,"label":"Generalized amyotrophy","onset_id":null,"reference":"OMIM:609241","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/116\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0012221\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0000116</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Alpha-N-acetylgalactosaminidase deficiency type 1 is an inherited condition that primarily causes neurological problems. There are three types of Alpha-N-acetylgalactosaminidase deficiencies. Alpha-N-acetylgalactosaminidase deficiency type 1, also called the infantile type, is the most severe form. Affected individuals may have developmental delay, developmental regression (they lose developmental skills), blindness, and seizures, and they eventually lose awareness of their surroundings and become unresponsive. People with this form of the condition usually don&#x27;t survive past early childhood. Alpha-N-acetylgalactosaminidase deficiency type 1 is caused by genetic changes in the NAGA gene. The condition follows an autosomal recessive pattern of inheritance.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/116\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"alpha-n-acetylgalactosaminidase-deficiency-type-1","sourceDocuments":[{"name":"GARD: Alpha-N-acetylgalactosaminidase deficiency type 1","reviewed":null,"source_release":"2026-10-25T03:38:10Z","url":"https://rarediseases.info.nih.gov/diseases/116"},{"name":"MONDO: alpha-N-acetylgalactosaminidase deficiency type 1","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0012221"}],"sourceNote":"","synonyms":["alpha-N-acetylgalactosaminidase deficiency, type 1","N-acetyl-alpha-D-galactosaminidase deficiency type III","NAGA deficiency type 1","NAGA deficiency, type 1","neuroaxonal dystrophy, Schindler type","Schindler disease type 1","Schindler disease type I","Schindler disease, type III"],"takeawayHtml":"","title":"alpha-N-acetylgalactosaminidase deficiency type 1"},"schemaVersion":1}
